BBNX ▼ -14.0% - Beta Bionics, Inc. $BBNX - Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm Beta Bionics shares fell 14.0% today despite the company announcing FDA clearance of its Mint patch pump and unveiling its 3D Intelligence insulin dosing algorithm. The decline suggests investors may have been disappointed by the timing of the announcement, competitive positioning, or other market factors, despite the regulatory milestone typically considered positive for medical device companies. 14-SEP-2026 07:30 AM ET